Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

NCT: NCT06827990 · RECRUITING

NCT IDNCT06827990
StatusRECRUITING
Start Date2025-09-22
Completion2031-09-01

Brief Summary

To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.

Frequently Asked Questions

What is GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections?

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections is a clinical trial registered under NCT06827990. Current status: RECRUITING.

What is the status of NCT06827990?

The current status of NCT06827990 (GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections) is: RECRUITING.

When did GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections start?

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections started on 2025-09-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑